COVID19 Severity Prediction and Health Services Research Evaluation

Summary

1\. Objectives: 1.-To create risk stratification scales of poor evolution in patients infected by SARS-CoV-2. 2.-Evaluate the accessibility and equity that these patients have had in the different care processes, diagnostic and therapeutic procedures, with special interest in patients who came from residences, by age, gender or geographic origin.3.-Evaluate the effectiveness of different therapeutic schemes that have been used in this pandemic. 4.-Evaluate the effectiveness of different diagnostic tests used to predict the poor evolution of these patients 5.- Evaluate the real costs associated with the treatment of hospitalized patients with COVID-19 ; 2. Methods: Information will be recorded from electronic medical record: epidemiological data, onset of symptoms, comorbidities and their treatments, symptoms, analytical data, vital signs, tests performed, treatments during admission and evolution up to 3 months after discharge. Statistical analysis: The investigators will use classic survival models, logistic regression, generalized linear models and also analysis using artificial intelligence techniques . Health care costs are assessed. Applications for decision making will be derived as a product.

Conditions

• Covid19

Interventions

OTHER

Predictors adverse evolution

Predictors adverse evolution in all hospital participant admitted patients

OTHER

Predictors of health care provide

Predictors of death, unequity, variability in process of care, cost in all COVID positive patients form the Basque Country

Sponsors & Collaborators

• Hospital Costa del Sol

  collaborator OTHER

• Hospital del Mar

  collaborator OTHER

• University Hospital of the Nuestra Señora de Candelaria

  collaborator OTHER

• Instituto de Salud Carlos III

  collaborator OTHER_GOV

• Hospital Universitario Araba

  collaborator OTHER

• Biocruces Bizkaia Health Research Institute

  collaborator OTHER_GOV

• Hospital de Basurto

  collaborator OTHER

• Hospital Donostia

  collaborator OTHER

• Hospital Galdakao-Usansolo

  lead OTHER_GOV

Principal Investigators

• Susana Garcia-Gutierrez, PhD · Hospital Galdakao-Usansolo

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-06-01

Primary Completion

2022-12-30

Completion

2022-12-31

Countries

• Spain

Study Locations